Transoral endocrine surgery (TES) is a scarless approach to thyroidectomy and parathyroidectomy for well-selected patients. Criteria for the TES approach to thyroidectomy include thyroid diameter less than or equal to 10 cm, benign nodule less than or equal to 6 cm, or confirmed or suspected malignant nodule less than or equal to 2 cm....
✦ The floor
Discussion
Signed responses from readers of the wire.
✦ Clinical Takeaway ✦
No actionable change — this article covers thyroid/parathyroid surgery and has no relevance to audiology clinical practice.
✦ Why It Matters ✦
This article has no relevance to the audiology field and should be excluded from audiology-focused content pipelines.
✦ Key Points ✦
- 01Covers transoral endocrine surgery (TES) for scarless thyroid and parathyroid removal.
- 02Not related to audiology, hearing loss, or vestibular disorders.
- 03Published in Clinics in Laboratory Medicine.
- 04Intended audience is surgeons and pathologists, not audiologists.
- 05Included here likely due to a content-feed classification error.
✦ Research metadata ✦
- PMID
- 42526977
- DOI
- 10.1016/j.cll.2026.06.013.
- Journal
- Clinics in Laboratory Medicine
- Publication type
- review
- Evidence level
- 5
- Population
- Patients undergoing transoral endocrine surgery
- Intervention
- Transoral endocrine surgery (TES)
Primary outcomes
Patient selection criteria; Pathology implications of TES